Immunogenicity and Safety Study of GlaxoSmithKline Biological's Live Attenuated Measles Mumps Rubella Varicella Vaccine (PriorixTetra™) When Co-administered With Conjugated Meningococcal C Vaccine (Meningitec®, Nuron Biotechs' Vaccine) in Healthy Children

Name: Immunogenicity and Safety Study of GlaxoSmithKline Biological's Live Attenuated Measles Mumps Rubella Varicella Vaccine (PriorixTetra™) When Co-administered With Conjugated Meningococcal C Vaccine (Meningitec®, Nuron Biotechs' Vaccine) in Healthy Children
Creator: Vivli
Published: 2019-04-22T15:48:11+08:00

DataCite Commons2025-05-01 更新2026-05-07 收录

疫苗联合接种评估

儿童免疫原性研究

数据链接：

https://search.vivli.org/doiLanding/studies/00003805/isLanding 数据链接链接失效反馈

官方服务：

资源简介：

The purpose of this study is to assess the immunogenicity and safety of GSK Biologicals' investigational measles, mumps, rubella and varicella (MMRV) vaccine (GSK208136, PriorixTetra™) when co-administered along with conjugated Meningococcal C (MenC) vaccine (Meningitec®, Nuron Biotechs' Vaccine) in healthy children.

提供机构：

Vivli

创建时间：

2019-04-22